Cancer Screen analyses germline mutations across 49 genes that are associated with 17 types of hereditary cancer, including some of the most commonly occurring cancers such as hereditary breast, ovarian, colorectal, prostate and stomach cancer.
Potentially improves outcomes for patients identified as carriers of mutations with targeted surveillance or early intervention.
Avoiding unnecessary interventions
Avoids unnecessary interventions for patients who do not test positive for the mutation known in their family.
Counsel patients on the underlying genetic causes of hereditary cancer in their family.